FDA Approval for Trabectedin. Use in Cancer. Trabectedin is approved to treat: Liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have metastasized (spread to other parts of the body). It is used in patients who have already been treated with anthracycline chemotherapy. Trabectedin is also being studied in the treatment of other types of cancer. More About Trabectedin. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. MedlinePlus Information on Trabectedin - A lay language summary of important information about this drug that may include the following: warnings about this drug, what this drug is used for and how it is used,
Blood Clots in Urine. Blood clots in urine can be a sign of an internal injury that causes bleeding, inflammation, or disease. The medical term used for blood in the urine is hematuria. Blood clots in urine obviously result from large enough bleeding to turn the color of urine red and have visible clots. Visible presence of blood in urine is called gross hematuria. Some of the most common causes of blood clots in urine are kidney diseases or other urinary tract problems.
Gross hematuria produces pink, red or cola-colored urine due to the presence of red blood cells. It takes little blood to produce red urine, and the bleeding usually isn't painful. Passing blood clots in your urine, however, can be painful.